At the therapeutic fondaparinux concentration (1.2 μg/mL), we observed a decreasing trend in PP response induced by plasma from 4 patients who clinically responded to fondaparinux therapy ( Figure 2F ).
← all excerpts
A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
1
—
—